Trial
NCT02902484
Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
University of Texas Southwestern Medical Center
Collaborators
Boehringer Ingelheim; The University of Texas Health Science Center at San Antonio; South Plains Oncology Consortium
Condition
Cancer of Pancreas
Intervention
Nintedanib
Why stopped
The study was terminated due to futility and lack of future funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-03